Pangenomic Health Inc.

Research Pangenomic Health Inc. (LL3) on Bullrun: market cap EUR 4.21M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 4.21M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 0-CAD 3.43M-CAD 1.88Mn/an/aCAD 38.77KCAD 212.87K-CAD 2.19M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25EUR 4.21Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Pangenomic Health Inc.

Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Pangenomic Health Inc.'s market cap?

Pangenomic Health Inc.'s market capitalization is EUR 4.21M.

What does Pangenomic Health Inc. do?

Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness. It also provides MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports.